ELOTUZUMAB - INJECTION
PHONETIC PRONUNCIATION: (EL-oh-TOOZ-ue-mab)
COMMON BRAND NAME(S): Empliciti
GENERIC NAME(S): elotuzumab
Uses
USES: Elotuzumab is used along with other medications (lenalidomide, dexamethasone) to treat a certain type of cancer (multiple myeloma).
How to use ELOTUZUMAB - INJECTION
HOW TO USE: Read the Patient Information Leaflet if available from your pharmacist before you start using elotuzumab and each time you receive the medication. If you have any questions, ask your doctor or pharmacist. This medication is given by injection into a vein by a health care professional. It is given as directed by your doctor, usually once a week for the first 8 weeks. After that it is usually given once every 2 weeks. The dosage is based on your weight. To help prevent side effects (infusion reactions), your doctor may direct you to use other medications before you receive this medication. Use these additional medications exactly as directed by your doctor. Tell your doctor right away if you have any symptoms of infusion reactions such as fever, chills, dizziness, and slow heartbeat.
Side Effects
Precautions
Interactions
Overdose
Images
Reviews
Faq for ELOTUZUMAB - INJECTION
Elotuzumab injection is used to treat multiple myeloma, a type of cancer that affects plasma cells in the bone marrow.
Elotuzumab works by targeting a specific protein called SLAMF7, which is found on multiple myeloma cells. By binding to SLAMF7, elotuzumab activates the body's immune system to attack and kill the cancer cells.
Elotuzumab injection is given directly into a vein (intravenous infusion) by a healthcare professional.
Common side effects of elotuzumab injection include fatigue, fever, cough, diarrhea, constipation, nausea, infections, and rash. It is important to discuss any side effects with your healthcare provider.
Elotuzumab injection should not be used by individuals with a known allergy to elotuzumab or any of the components of the medication. It is important to inform your healthcare provider about any allergies or medical conditions you have before starting treatment.
The duration of elotuzumab treatment can vary depending on individual response and treatment plan. It may be prescribed as part of a combination therapy, and the treatment duration will be determined by your healthcare provider.
Elotuzumab injection is not a cure for multiple myeloma but is used as a part of a treatment plan to help control the disease and improve overall survival. It is important to continue follow-up appointments and treatments as recommended by your healthcare provider.
Elotuzumab injection may interact with certain medications, including immunosuppressants and live vaccines. It is important to inform your healthcare provider about all medications and vaccines you are taking before starting treatment with elotuzumab.
The dosing frequency of elotuzumab injection can vary depending on the treatment plan prescribed by your healthcare provider. Typically, elotuzumab is given once a week for the first two cycles and then every two weeks thereafter.
Disclaimer
IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
No Reviews Yet